• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Request Membership
Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • 用户
  • 登录
  • 注册
  • 会员
  • 注销
  • 账号
  • 密码重置
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • 用户
  • 登录
  • 注册
  • 会员
  • 注销
  • 账号
  • 密码重置
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • primary care
Evaluating Peer Coaching for Weight Management in Primary Care: Insights from a VA-Based Cluster Randomized Clinical Trial
Posted inClinical Updates Wellness & Lifestyle

Evaluating Peer Coaching for Weight Management in Primary Care: Insights from a VA-Based Cluster Randomized Clinical Trial

Posted by By MedXY 09/13/2025
A cluster randomized trial in veterans assessed peer coaching for weight management, showing improved program attendance but no significant 12-month weight loss difference versus enhanced usual care.
Read More
Impact of Physician-Personalized Videos and Infographics on Influenza Vaccination Rates: Findings from a Randomized Clinical Trial
Posted inClinical Updates Wellness & Lifestyle

Impact of Physician-Personalized Videos and Infographics on Influenza Vaccination Rates: Findings from a Randomized Clinical Trial

Posted by By MedXY 09/11/2025
This trial assessed if videos and infographics from primary care physicians improve flu vaccination rates; overall effects were minimal, but notable improvements occurred in children.
Read More
Enhancing Opioid Use Disorder Care in Primary Settings: Impact of an EHR-Integrated Clinical Decision Support System
Posted inClinical Updates Wellness & Lifestyle

Enhancing Opioid Use Disorder Care in Primary Settings: Impact of an EHR-Integrated Clinical Decision Support System

Posted by By MedXY 09/11/2025
A cluster randomized trial demonstrates that an electronic health record–integrated clinical decision support system increases naloxone prescriptions and opioid use disorder treatments in primary care but does not change diagnosis rates or MOUD adherence.
Read More
AI Versus Family Physicians: Evaluating ChatGPT-4o’s Responses to Common Primary Care Queries
Posted inClinical Updates Wellness & Lifestyle

AI Versus Family Physicians: Evaluating ChatGPT-4o’s Responses to Common Primary Care Queries

Posted by By MedXY 08/27/2025
This study compares ChatGPT-4o and family physicians in answering 200 common primary care questions, revealing AI’s superior performance in appropriateness, accuracy, comprehensiveness, and empathy, highlighting its potential in enhancing primary care.
Read More
Global Patterns and Challenges of Antibiotic Prescribing in Primary Care: A Comprehensive Systematic Review and Meta-Analysis
Posted inClinical Updates Wellness & Lifestyle

Global Patterns and Challenges of Antibiotic Prescribing in Primary Care: A Comprehensive Systematic Review and Meta-Analysis

Posted by By MedXY 08/21/2025
A global meta-analysis reveals that over 40% of primary care prescriptions contain antibiotics, with more than half being inappropriate, highlighting urgent needs for improved antimicrobial stewardship worldwide.
Read More
AI-Enhanced Spirometry Interpretation in Primary Care: Evidence from a Randomized Controlled Trial
Posted inClinical Updates Wellness & Lifestyle

AI-Enhanced Spirometry Interpretation in Primary Care: Evidence from a Randomized Controlled Trial

Posted by By MedXY 08/05/2025
AI decision support significantly improves primary care clinicians’ accuracy in spirometry diagnosis, especially for COPD, addressing a key gap in respiratory disease management.
Read More
  • Obrixtamig (BI 764532): A Promising DLL3/CD3 T-Cell Engager in Heavily Pretreated DLL3-Positive Neuroendocrine Cancers
  • Innovative Combination of Cryoablation and Intratumoral Immunotherapy Extends Survival in Advanced Metastatic Cancer
  • The Withdrawal of OCALIVA: Impact and Implications for Primary Biliary Cholangitis Treatment
  • PegIFN Alpha-2a Therapy Reduces Relapse Risk after NUC Discontinuation in HBeAg-Negative Chronic Hepatitis B: Insights from a Randomized Controlled Trial
  • Rapirosiran: A Promising RNA Interference Therapy Targeting HSD17B13 for Metabolic Dysfunction-Associated Steatohepatitis
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging AI artificial intelligence blood pressure breast cancer béo phì cardiovascular health cardiovascular risk clinical trial COPD COVID-19 diabetes diet dinh dưỡng exercise GLP-1 health heart failure HFpEF Hypertension immunotherapy inflammation longevity MASH MASLD mental health metformin Mortality nutrition obesity Pregnancy prevention public health randomized trial semaglutide sexual health Suy Tim sức khỏe tim mạch thử nghiệm lâm sàng tirzepatide type 2 diabetes weight loss wellness women's health 心力衰竭

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top